| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Belite Bio (NASDAQ:BLTE) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-14. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Belite Bio will report an earnings per share (EPS) of $-0.37.
Anticipation surrounds Belite Bio's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
During the last quarter, the company reported an EPS missed by $0.01, leading to a 0.84% increase in the share price on the subsequent day.
Here's a look at Belite Bio's past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.29 | -0.25 | -0.28 |
| EPS Actual | -0.32 | -0.28 | -0.26 | -0.33 |
| Price Change % | 1.0% | 1.0% | 0.0% | 1.0% |
Shares of Belite Bio were trading at $61.99 as of May 12. Over the last 52-week period, shares are up 45.11%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Belite Bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: BLTE
